Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
NewAmsterdam Pharma Company NV banner
N

NewAmsterdam Pharma Company NV
NASDAQ:NAMS

Watchlist Manager
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Watchlist
Price: 30.6 USD 0.66% Market Closed
Market Cap: $3.6B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...

Wall St Price Targets

NAMS Price Targets Summary
NewAmsterdam Pharma Company NV

Wall Street analysts forecast NAMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NAMS is 52.24 USD with a low forecast of 38.38 USD and a high forecast of 63 USD.

NAMS Lowest Forecast
38.38 USD
25% Upside
NAMS Average Forecast
52.24 USD
71% Upside
NAMS Highest Forecast
63 USD
106% Upside
Lowest Forecast
Price Target
38.38 USD
25% Upside
Average Forecast
Price Target
52.24 USD
71% Upside
Highest Forecast
Price Target
63 USD
106% Upside
NewAmsterdam Pharma Company NV Competitors:
Price Targets
TELA
TELA Bio Inc
187% Upside
EOLS
Evolus Inc
122% Upside
TELA
TELA Bio Inc
187% Upside
EOLS
Evolus Inc
122% Upside

Revenue
Forecast

N/A
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 6 years is 28%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

See Also

Summary
NAMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
NAMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NAMS stock valuation using valuation multiples.
Wall St Estimates
NAMS price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NAMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other NewAmsterdam Pharma Company NV listings:
F • EUR
KH6
 DUS • EUR
KH6
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NAMS's stock price target?
Price Target
52.24 USD

According to Wall Street analysts, the average 1-year price target for NAMS is 52.24 USD with a low forecast of 38.38 USD and a high forecast of 63 USD.

What is the Revenue forecast for NewAmsterdam Pharma Company NV?
Projected CAGR
28%

The compound annual growth rate for Revenue over the next 6 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join 343,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett